BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shen B, Zhang D, Zeng X, Guan L, Yang G, Liu L, Huang J, Li Y, Hong S, Li L. Cannabidiol inhibits methamphetamine-induced dopamine release via modulation of the DRD1-MeCP2-BDNF-TrkB signaling pathway. Psychopharmacology (Berl) 2022. [PMID: 34997862 DOI: 10.1007/s00213-021-06051-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Shen B, Zhang R, Yang G, Peng Y, Nie Q, Yu H, Dong W, Chen B, Song C, Tian Y, Qin L, Shu J, Hong S, Li L. Cannabidiol prevents methamphetamine-induced neurotoxicity by modulating dopamine receptor D1-mediated calcium-dependent phosphorylation of methyl-CpG-binding protein 2. Front Pharmacol 2022;13:972828. [DOI: 10.3389/fphar.2022.972828] [Reference Citation Analysis]
2 Chivero ET, Sil S, Kumar M, Buch S. Substance use, microbiome and psychiatric disorders. Pharmacol Biochem Behav 2022;219:173432. [PMID: 35905802 DOI: 10.1016/j.pbb.2022.173432] [Reference Citation Analysis]